precedex ready to use dexmedetomidine hydrochloride 80 micrograms/20 ml injection for intravenous infusion vial
pfizer australia pty ltd - dexmedetomidine hydrochloride, quantity: 4.72 microgram/ml (equivalent: dexmedetomidine, qty 4 microgram/ml) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation: for sedation of initially intubated adult patients during treatment in an intensive care setting. the use of precedex ready to use by continuous infusion in these patients should not exceed 24 hours.,procedural sedation: for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.
dexmedetomidine fresenius dexmedetomidine (as hydrochloride) 200 microgram/2 ml concentrated injection vial
fresenius kabi australia pty ltd - dexmedetomidine hydrochloride, quantity: 236 microgram (equivalent: dexmedetomidine, qty microgram) - injection, concentrated - excipient ingredients: sodium chloride; water for injections - icu sedation: for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine fresenius by continuous infusion in these patients should not exceed 24 hours. procedural sedation: for sedation of non-intubated patients prior to and/or during surgical and other procedures.
dexdomitor 0.1 mg/ml injectable sedative and analgesic for dogs and cats
jurox pty limited - dexmedetomidine hydrochloride - parenteral liquid/solution/suspension - dexmedetomidine hydrochloride active 0.1 mg/ml - anaesthetics/analgesics
sedastart 1 mg/ml solution for injection for cats and dogs
le vet beheer b.v. - medetomidine hydrochloride - medetomidine hydrochloride 1 g/litre - analgesic
dexmedetomidine hydrochloride in 0.9% sodium chloride injection
sandoz inc. - dexmedetomidine hydrochloride (unii: 1018wh7f9i) (dexmedetomidine - unii:67vb76hono) - dexmedetomidine hydrochloride in 0.9% sodium chloride injection is indicated for sedation of initially intubated and mechanically ventilated adult patients during treatment in an intensive care setting. dexmedetomidine hydrochloride in 0.9% sodium chloride injection should be administered by continuous infusion not to exceed 24 hours. dexmedetomidine hydrochloride in 0.9% sodium chloride injection has been continuously infused in mechanically ventilated adult patients prior to extubation, during extubation, and post-extubation. it is not necessary to discontinue dexmedetomidine hydrochloride in 0.9% sodium chloride injection prior to extubation. dexmedetomidine hydrochloride in 0.9% sodium chloride injection is indicated for sedation of non-intubated adult patients prior to and/or during surgical and other procedures. pediatric use information is approved for hospira, inc.’s precedex tm (dexmedetomidine hydrochloride in sodium chloride injection). however, due to hospira, inc.’s marketing exclusivity righ
sileo 0.1 mg/ml oromucosal gel for dogs
mavlab animal health pty ltd - dexmedetomidine hydrochloride - oral gel - dexmedetomidine hydrochloride active 0.1 mg/ml - central nervous system
sileo 0.1 mg/ml oromucosal gel for dogs
mavlab animal health limited - dexmedetomidine hydrochloride - dexmedetomidine hydrochloride 0.1 g/kg - behaviour modifier
sedastart 1 mg/ml solution for injection for cats and dogs
le vet bv - medetomidine hydrochloride - solution for injection - 1 milligram(s)/millilitre - medetomidine - cats, dogs - neurological preparations
dormostart 1 mg/ml solution for injection for dogs and cats
alfasan nederland b.v - medetomidine hydrochloride - solution for injection - medetomidine
dexmedetomidine ever pharma dexmedetomidine (as hydrochloride) 200 microgram/2 ml concentrated injection ampoule
interpharma pty ltd - dexmedetomidine hydrochloride, quantity: 236.4 microgram (equivalent: dexmedetomidine, qty 200 microgram) - injection, concentrated - excipient ingredients: sodium chloride; water for injections - icu sedation.,for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine ever pharma by continuous infusion in these patients should not exceed 24 hours.,procedural sedation,for sedation of non-intubated patients prior to and/or during surgical and other procedures.